Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO criteria

Molecular Diagnosis and Therapy

Volumn 11, Issue 1, 2007, Pages 29-53

  Tan, Leonard Hwan Cheong ^a,b   Chiu, Lily Lily ^c   Koay, Evelyn Siew Chuan ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN;

ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER GRADING; CELL LINEAGE; CELL PROLIFERATION; CELL SIZE; CLINICAL ARTICLE; GENE REARRANGEMENT; HEAVY CHAIN; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHATIC SYSTEM TUMOR; LYMPHOID HYPERPLASIA; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REED STERNBERG CELL; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

HUMAN HERPESVIRUS 4;

EID: 33846961067     PISSN: 11771062     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256221     Document Type: Article

References (96)

1. Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics: tumors of haematopoeitic and lymphoid tissues. World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer, 2001
2. Gulley ML. Antigen receptor gene rearrangements. In: Leonard DGB, editor. Diagnostic molecular pathology: major problems in pathology. Vol. 41. Philadelphia (PA): Saunders, 2003: 118-24
3. Pan L, Cesarman E, Knowles DM. Antigen receptor genes: structure, function and genetic analysis of their rearrangements. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia (PA): Williams and Wilkins, 2001: 307-28
4. Antigen receptor genes and analysis of their rearrangements. In: Warnke RA, Weiss LM, Chan JKC, et al., editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology, 3rd series, fascicle 14. Washington DC: US Armed Forces Institute of Pathology, 1994: 31-4
5. Evens AM, Gartenhaus RB. Treatment of T-cell non-Hodgkin's lymphoma. Curr Treat Options Oncol 2004 Aug; 5 (4): 289-303
6. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004 Apr; 103 (7): 2474-9
7. Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004 Oct; 15 (10): 1467-75
8. Sehn LH, Connors JM. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective. Oncology (Williston Park) 2005 Apr; 19 (4 Suppl. 1): 26-34
9. Coiffier B, Reyes F. Groupe d'Etude des Lymphomes de l'Adulte. Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective. Oncology (Williston Park) 2005 Apr; 19 (4 Suppl. 1): 7-15
10. Fisher RI, Miller TP, O'Connor OA. Diffuse aggressive lymphoma. Hematology (Am Soc Hematol Educ Program) 2004; 2004: 221-36
11. Younes A. New treatment strategies for aggressive lymphoma. Semin Oncol 2004 Dec; 31 (6 Suppl. 15): 10-3
12. Coiffier B. Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma. Semin Oncol 2004 Feb; 31 (1 Suppl. 2): 7-11
13. Kadin ME. Hodgkin's disease: cell of origin, immunobiology and pathogenesis. In: Knowles DM, editor. Neoplastic hematopathology. Philadelphia (PA): Williams and Wilkins, 2001: 667-90
14. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, et al. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2000; 21: 4908-20
15. Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-50
16. Theil J, Laumen H, Marafioti T, et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood 2001 May 15; 97 (10): 3191-6
17. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84 (5): 1361-92
18. Jaffe ES. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 2001; 14 (3): 219-28
19. Weisenburger DD, Anderson JR, Diebold J, et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Am J Hematol 2001; 67 (3): 172-8
20. Tan LHC, Chong SM. Grade II nodular sclerosing Hodgkin lymphoma commonly mimics non-Hodgkin lymphomas with anaplastic morphology: a pathologic review of 42 cases reclassified by current WHO criteria [abstract]. Mod Pathol 2003 Jan; 16 (1): 255A
21. Tan LHC, Do E, Tan SY, et al. Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe (FISH) for Anaplastic Lymphoma Kinase gene rearrangement: a study of 101 cases characterized by immunohistomorphology on fixed archival tissue. Mol Diagn 2004; 8 (4): 213-29
22. Tan LHC, Do E, Chong SM, et al. Detection of ALK gene rearrangements in formalin-fixed, paraffin-embedded tissue using a fluorescence in-situ hybridization (FISH) probe: a search for optimum conditions of tissue archiving and preparation for FISH. Mol Diagn 2003 Mar; 7 (1): 27-33
23. Chang TL, Salto-Tellez M, Thamboo TP, et al. Diagnostic validation of capillary electrophoresis analysis of T-cell receptor γ-chain gene rearrangements: prediction of malignant transformation of cutaneous T-cell lymphoproliferative disorders. Clin Chemistry 2003; 49 (3): 513-5
24. Sioutos N, Bagg A, Michaud GY, et al. Polymerase chain reaction versus Southern blot hybridization: detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1995 Mar; 4 (1): 8-13
25. McCarthy KP, Sloane JP, Kabarowski JHS, et al. The rapid detection of clonal T-cell proliferation in patients with lymphoid disorders. Am J Pathol 1991 Apr; 138 (4): 821-8
26. Classic Hodgkin's disease. In: Warnke RA, Weiss LM, Chan JKC, et al., editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology, 3rd series, fascicle 14. Washington DC: US Armed Forces Institute of Pathology, 1994: 227-314
27. Achten R, Verhoef G, Vanuytsel L, et al. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 2002 Jan; 40 (1): 31-45
28. Achten R, Verhoef G, Vanuytsel L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 2002 Mar 1; 20 (5): 1269-77
29. Lim MS, Beaty M, Sorbara L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 2002 Nov; 26 (11): 1458-66
30. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988 Jun; 12 (6): 433-43
31. Lorenzen J, Li G, Zhao-Hohn M, et al. Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues. Virchows Arch 1994; 424 (6): 593-600
32. Jones D, Jorgensen JL, Shahsafaei A, et al. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol 1998 Aug; 22 (8): 956-64
33. Lee S-S, Rudiger T, Odenwald T, et al. Angioimmunoblastic T-cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 2003; 103: 12-20
34. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99 (2): 627-33
35. Kojima M, Nakamura S, Itoh H, et al. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: a clinicopathological and immunohistochemical study of 10 cases. APMIS 2001; 109: 699-706
36. Steinhoff M, Hummel M, Assaf C, et al. Cutaneous T cell lymphoma and classic Hodgkin lymphoma of B cell type within a single lymph node: composite lymphoma. J Clin Pathol 2004 Mar; 57 (3): 329-31
37. Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 1999; 23 (10): 1233-40
38. Higgins JP, van de Rijn M, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol 2000; 114 (2): 236-47
39. Schwarting R, Gerdes J, Durkop H, et al. Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989 Oct; 74 (5): 1678-89
40. Piris M, Brown DC, Gatter KC, et al. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990 Sep; 17 (3): 211-8
41. Lukes RL, Tindle BH. Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975 Jan 2; 292 (1): 1-8
42. Knecht H, Berger C, Rothenberger S, et al. The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001; 60: 289-302
43. Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection: a different subtype of AILD-TL? Leukemia 2002; 16: 2134-41
44. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002; 117 (3): 368-79
45. Ho JWY, Ho FSC, Chan ACL, et al. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 1998; 185: 79-85
46. Nakamura S, Sasajima Y, Koshikawa T, et al. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T- cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus. Pathol Int 1995; 45 (120): 958-64
47. Willenbrock K, Roes A, Seidl C, et al. Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-β gene rearrangements. Am J Pathol 2001; 158 (5): 1851-7
48. Smith JL, Hodges E, Quin CT, et al. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000 Feb; 156 (2): 661-9
49. Diss TC, Watts M, Pan LX, et al. The polymerase chain reaction in the detection of monoclonality in T-cell lymphomas. J Clin Pathol 1995; 48: 1045-50
50. Polliack A, Lugassy G. Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia 1992; 6 Suppl. 4: 152-4
51. Pavlidis NA, Klouvas G, Tsokos M, et al. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders: a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 1995; 16 (5-6): 477-82
52. Yataganas X, Papadimitriou C, Pangalis G, et al. Angio-immunoblastic lymphadenopathy terminating as Hodgkin's disease. Cancer 1977 May; 39 (5): 2183-9
53. Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993 Mar; 169 (3): 291-5
54. Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B cell neoplasms and B cell chronic lymphocytic leukemia in the Japanese population. Pathol Int 1999 Jul; 49 (7): 595-600
55. Stein H, Foss HD, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000 Dec 1; 96 (12): 3681-95
56. Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood 1999 Nov 1; 94 (9): 3108-13
57. Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997 Mar 1; 89 (5): 1483-90
58. Gascoyne RD, Lamant L, Martin-Suberto JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003 Oct; 102 (7): 2568-73
59. De Paepe P, Baens M, van Krieken H, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003 Oct; 102 (7): 2638-41
60. Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003 Oct; 102 (7): 2642-4
61. Falini B, Pulford K, Pucciarini A, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999 Nov 15; 94 (10): 3509-15
62. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997 Feb; 89 (4): 1394-404
63. Tan LHC. ALK-positive anaplastic T-cell lymphoma, combined small-cell/lymphohistiocytic variant, mimicking Kikuchi-Fujimoto (subacute/histiocytic necrotizing) lymphadenitis. In: Cooke RA, editor. Surgical pathology: a Singapore-Malaysia experience. Slide seminar, XXV Congress of the International Academy of Pathology; 2004 Oct 11-16; Brisbane. Brisbane: Knowledge Books and Software, 2004: 79-89
64. Beaubier NT, Hart AP, Bartolo C, et al. Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction. Diagn Mol Pathol 2000; 9 (3): 121-31
65. Sprouse J, Werling R, Hanke D, et al. T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gamma-chain gene and capillary electrophoresis of fluorescently-labelled products. Am J Clin Pathol 2000; 113: 838-50
66. Simon M, Kind P, Kaudewitz P, et al. Automated high-resolution polymerase chain reaction fragment analysis. A method for detecting T-cell receptor gamma-chain gene rearrangements in lymphoproliferative diseases. Am J Pathol 1998; 152 (1): 29-33
67. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998 Mar 15; 91 (6): 2076-84
68. Tan LHC, Chen CS, Mow BMF, et al. Medullary myeloid disorders in young patients negate large-cell lymphoma and favor extramedullary myeloblastic tumor/granulocytic sarcoma. Proceedings of the 4th Asia-Pacific International Academy of Pathology Congress; 2005 Aug 23-26; Beijing. Bologna: Medimond International Proceedings, 2005: 119-23
69. Sanchez I, San Miguel JF, Corral J, et al. Gene rearrangement in acute non-lymphoblastic leukaemia: correlation with morphological and immunophenotypic characteristics of blast cells. Br J Haematol 1995 Jan; 89 (1): 104-9
70. Paietta E, Van Ness B, Bennett J, et al. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations. Br J Haematol 1992 Oct; 82 (2): 324-31
71. Rudiger T, Jaffe ES, Delsol G, et al. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol 1998; 9 Suppl. 5: S31-8
72. Mohrmann RL, Arber DA. CD20-positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mod Pathol 2000 Nov; 13 (11): 1244-52
73. Hodges E, Krishna MT, Pickard C, et al. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2003; 56: 1-11
74. Ye MQ, Suriawinata A, Black C, et al. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch Pathol Lab Med 2000 Apr; 124 (4): 604-8
75. Prabhu RM, Medeiros LJ, Kumar D, et al. Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol 1998 Apr; 11 (4): 404-10
76. Stroehmann A, Dorner T, Lukowsky A, et al. Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjogren's syndrome. J Rheumatol 2002 Jun; 29 (6): 1326-9
77. Childs CC, Parham DM, Berard CW. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils. Am J Surg Pathol 1987 Feb; 11 (2): 122-32
78. Tindle BH, Parker JW, Lukes RJ. "Reed-Sternberg cells" in infectious mononucleosis? Am J Clin Pathol 1972 Dec; 58 (6): 607-17
79. Lukes RJ. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res 1971 Nov; 31 (11): 1755-67
80. Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer 1971 Jun; 27 (6): 1277-94
81. Van Parys G, de Wolf-Peeters C, van den Oord JJ, et al. Lymph node architecture in Hodgkin's disease: evidence for the role of the composite nodule in nodular sclerosing Hodgkin's disease. Hematol Oncol 1987 Apr-Jun; 5 (2): 147-54
82. Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000 Sep 1; 96 (5): 1889-99
83. Cabone A, Gloghini A, Gaidano G, et al. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood 1998 Oct 1; 92 (7): 2220-8
84. Carbone A, Gloghini A, Aldinucci D, et al. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease. Br J Haematol 2002 May; 117 (2): 366-72
85. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002 Jun 15; 99 (12): 4283-97
86. Tsang WY, Chan JK, Sing C. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Clin Pathol 1993 Mar; 99 (3): 317-23
87. Roers A, Montesinos-Rongen M, Hansmann ML, et al. Amplification of TCRbeta gene rearrangements from micromanipulated single cells: T cells rosetting around Hodgkin and Reed-Sternberg cells in Hodgkin's disease are polyclonal. Eur J Immunol 1998 Aug; 28 (8): 2424-31
88. Poppema S, Potters M, Visser L, et al. Immune escape mechanisms in Hodgkin's disease. Ann Oncol 1998; 9 Suppl. 5: S21-4
89. Cazals-Hatem D, Andre M, Mounier N, et al. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87). Am J Surg Pathol 2001 Mar; 25 (3): 297-306
90. Brousset P, Rochaix P, Chittal S, et al. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993 Aug; 23 (2): 189-91
91. Calame C, Lin K-I, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003; 21: 205-30
92. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005 Dec; 29 (12): 1633-41
93. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005 Jun; 18 (6): 806-15
94. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004 Jun; 28 (6): 736-47
95. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. London: Prentice-Hall, 1994: 143-61
96. Seow A, Koh WP, Chia KS, et al. Trends in cancer incidence in Singapore 1968-2002. Report No. 6. Singapore: Singapore Cancer Registry, 2004